ASTA Draft Risk Profile Comments
ASTA issued a comment to the Food and Drug Administration (FDA) in March 2014 regarding the FDA's Draft Risk Profile on Pathogens and Filth in Spice.
03/03/2014 at 5:15 am
1
Related Resources
Multi-Industry Letter to FDA on Possible Use of 3rd Party Audit Data
ASTA signed onto a letter from multiple industries to FDA's Associate Commissioner Michael Rogers in September 2024 requesting a meeting to discuss the potential use of 3rd party food safety audit data as part of the Agency's inspection strategy.
ASTA Comments to FDA on Voluntary Sesame Labeling Guidance
ASTA issued comments to the Food and Drug Administration (FDA) in February 2021 on the Voluntary Disclosure of Sesame as an Allergen: Guidance for Industry. Comments outline inconsistencies and confusion arising from the guidance, including that FDA policy already provides that sesame should not be labeled under the generic declaration of spices. ASTA requests that FDA revoke the voluntary guidance due to the legislative process and the FASTER Act.
